$CASI Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in CASI Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in CASI Pharmaceuticals, Inc.. Get notifications about new insider transactions in CASI Pharmaceuticals, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 30 2021 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Chairman and CEO | Buy | P | 2.05 | 3,000,000 | 6,150,000 | 3,000,000 | 0 to 3 M |
Dec 23 2020 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Chairman and CEO | Gift | G | 0.00 | 380,000 | 0 | 4,683,994 | 5.1 M to 4.7 M (-7.50 %) |
Dec 18 2020 | CASI | CASI Pharmaceutica ... | Xu Weihao | Chief Financial Off ... | Option Exercise | A | 2.61 | 800,000 | 2,088,000 | 800,000 | |
Dec 18 2020 | CASI | CASI Pharmaceutica ... | Xu Weihao | Chief Financial Off ... | Buy | P | 2.63 | 2,279 | 5,994 | 10,000 | 7.7 K to 10 K (+29.52 %) |
Dec 18 2020 | CASI | CASI Pharmaceutica ... | Xu Weihao | Chief Financial Off ... | Buy | P | 2.64 | 1,721 | 4,543 | 7,721 | 6 K to 7.7 K (+28.68 %) |
Dec 18 2020 | CASI | CASI Pharmaceutica ... | Xu Weihao | Chief Financial Off ... | Buy | P | 2.44 | 2,000 | 4,880 | 6,000 | 4 K to 6 K (+50.00 %) |
Nov 24 2020 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Chairman and CEO | Buy | P | 2.18 | 100,000 | 218,000 | 5,063,994 | 5 M to 5.1 M (+2.01 %) |
Nov 24 2020 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Chairman and CEO | Buy | P | 2.12 | 127,471 | 270,239 | 4,963,994 | 4.8 M to 5 M (+2.64 %) |
Jul 24 2020 | CASI | CASI Pharmaceutica ... | Zhang Larry | President | Buy | P | 1.90 | 20,153 | 38,291 | 20,153 | 0 to 20.2 K |
Jul 24 2020 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Chairman and CEO | Buy | P | 1.90 | 1,200,000 | 2,280,000 | 7,532,347 | 6.3 M to 7.5 M (+18.95 %) |
Jul 24 2020 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Chairman and CEO | Buy | P | 1.90 | 2,952,426 | 5,609,609 | 4,836,523 | 1.9 M to 4.8 M (+156.70 %) |
Jun 18 2020 | CASI | CASI Pharmaceutica ... | Zhou Quan | Director | Option Exercise | A | 2.63 | 67,429 | 177,338 | 67,429 | |
Jun 18 2020 | CASI | CASI Pharmaceutica ... | Huang James | Director | Option Exercise | A | 2.63 | 70,400 | 185,152 | 70,400 | |
Jun 18 2020 | CASI | CASI Pharmaceutica ... | Wu Yue Alexander | Director | Option Exercise | A | 2.63 | 68,800 | 180,944 | 68,800 | |
Jun 18 2020 | CASI | CASI Pharmaceutica ... | Salisbury Franklin Cary jr | Director | Option Exercise | A | 2.63 | 68,800 | 180,944 | 68,800 | |
Jun 18 2020 | CASI | CASI Pharmaceutica ... | SHROTRIYA RAJESH C MD | Director | Option Exercise | A | 2.63 | 61,257 | 161,106 | 61,257 | |
May 21 2020 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Chairman and CEO | Buy | P | 2.37 | 56,464 | 133,820 | 1,884,097 | 1.8 M to 1.9 M (+3.09 %) |
May 21 2020 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Chairman and CEO | Buy | P | 2.03 | 29,801 | 60,496 | 1,827,663 | 1.8 M to 1.8 M (+1.66 %) |
May 19 2020 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Chairman and CEO | Buy | P | 2.02 | 338,932 | 684,643 | 1,797,832 | 1.5 M to 1.8 M (+23.23 %) |
May 19 2020 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Chairman and CEO | Buy | P | 1.82 | 100,000 | 182,000 | 1,458,900 | 1.4 M to 1.5 M (+7.36 %) |
Mar 30 2020 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Chairman and CEO | Buy | P | 2.08 | 6,880 | 14,310 | 1,358,900 | 1.4 M to 1.4 M (+0.51 %) |
Mar 27 2020 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Chairman and CEO | Buy | P | 2.09 | 328,095 | 685,719 | 1,352,020 | 1 M to 1.4 M (+32.04 %) |
Mar 27 2020 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Chairman and CEO | Buy | P | 1.94 | 196,398 | 381,012 | 1,023,925 | 827.5 K to 1 M (+23.73 %) |
Mar 19 2020 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Chairman and CEO | Buy | P | 1.57 | 234,488 | 368,146 | 6,332,347 | 6.1 M to 6.3 M (+3.85 %) |
Mar 19 2020 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Chairman and CEO | Buy | P | 1.52 | 501,322 | 762,009 | 6,097,859 | 5.6 M to 6.1 M (+8.96 %) |
Mar 19 2020 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Chairman and CEO | Buy | P | 1.50 | 264,192 | 396,288 | 5,596,537 | 5.3 M to 5.6 M (+4.95 %) |
Jan 06 2020 | CASI | CASI Pharmaceutica ... | Wealth Strategy Holding Ltd | 10% Owner | Option Exercise | X | 1.69 | 493,827 | 834,568 | 0 | |
Jan 06 2020 | CASI | CASI Pharmaceutica ... | Wealth Strategy Holding Ltd | 10% Owner | Buy | X | 1.69 | 493,827 | 834,568 | 9,087,888 | 8.6 M to 9.1 M (+5.75 %) |
Dec 18 2019 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Chairman and CEO | Option Exercise | X | 1.69 | 374,321 | 632,602 | 0 | |
Dec 18 2019 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Chairman and CEO | Buy | X | 1.69 | 374,321 | 632,602 | 5,332,345 | 5 M to 5.3 M (+7.55 %) |
Dec 17 2019 | CASI | CASI Pharmaceutica ... | Zukiwski Alexander A | Chief Medical Offic ... | Option Exercise | A | 3.16 | 200,000 | 632,000 | 200,000 | |
Sep 24 2019 | CASI | CASI Pharmaceutica ... | Zhang Larry | President | Option Exercise | A | 3.35 | 200,000 | 670,000 | 200,000 | |
Aug 20 2019 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Chief Executive Off ... | Buy | P | 3.20 | 20,000 | 64,000 | 827,527 | 807.5 K to 827.5 K (+2.48 %) |
Aug 15 2019 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Chief Executive Off ... | Buy | P | 3.17 | 160,000 | 507,200 | 807,527 | 647.5 K to 807.5 K (+24.71 %) |
Jun 21 2019 | CASI | CASI Pharmaceutica ... | Wu Yue Alexander | Director | Option Exercise | A | 3.13 | 57,885 | 181,180 | 57,885 | |
Jun 21 2019 | CASI | CASI Pharmaceutica ... | SHROTRIYA RAJESH C MD | Director | Option Exercise | A | 3.13 | 51,538 | 161,314 | 51,538 | |
Jun 21 2019 | CASI | CASI Pharmaceutica ... | Salisbury Franklin Cary jr | Director | Option Exercise | A | 3.13 | 57,885 | 181,180 | 57,885 | |
Jun 21 2019 | CASI | CASI Pharmaceutica ... | Ren Ken Keyong | Director | Option Exercise | A | 3.13 | 51,538 | 161,314 | 51,538 | |
Jun 21 2019 | CASI | CASI Pharmaceutica ... | Huang James | Director | Option Exercise | A | 3.13 | 59,231 | 185,393 | 59,231 | |
Jun 21 2019 | CASI | CASI Pharmaceutica ... | Zhou Quan | Director | Option Exercise | A | 3.13 | 56,731 | 177,568 | 56,731 | |
Jun 21 2019 | CASI | CASI Pharmaceutica ... | He Wei-Wu | CEO | Option Exercise | A | 2.85 | 4,000,000 | 11,400,000 | 4,000,000 | |
Apr 04 2019 | CASI | CASI Pharmaceutica ... | SPECTRUM PHARMACEUTICALS INC | 10% Owner | Sell | J | 3.38 | 1,500,000 | 5,074,200 | 5,397,413 | 6.9 M to 5.4 M (-21.75 %) |
Jan 31 2019 | CASI | CASI Pharmaceutica ... | Ren Ken Keyong | Chief Executive Off ... | Option Exercise | A | 0.88 | 75,000 | 66,000 | 75,000 | |
Jan 31 2019 | CASI | CASI Pharmaceutica ... | Hu Cynthia W. | COO, Gen Counsel & ... | Option Exercise | A | 0.88 | 75,000 | 66,000 | 75,000 | |
Jan 15 2019 | CASI | CASI Pharmaceutica ... | Hu Cynthia W. | COO, Gen Counsel & ... | Option Exercise | M | 1.76 | 15,000 | 26,400 | 0 | |
Jan 15 2019 | CASI | CASI Pharmaceutica ... | Hu Cynthia W. | COO, Gen Counsel & ... | Payment of Exercise | F | 3.79 | 3,100 | 11,749 | 29,685 | 32.8 K to 29.7 K (-9.46 %) |
Jan 15 2019 | CASI | CASI Pharmaceutica ... | Hu Cynthia W. | COO, Gen Counsel & ... | Buy | M | 1.76 | 15,000 | 26,400 | 32,785 | 17.8 K to 32.8 K (+84.34 %) |
Dec 21 2018 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Director | Gift | G | 0.00 | 200,000 | 0 | 647,527 | 847.5 K to 647.5 K (-23.60 %) |
Dec 06 2018 | CASI | CASI Pharmaceutica ... | Ren Ken Keyong | Chief Executive Off ... | Option Exercise | A | 0.99 | 720,000 | 712,800 | 720,000 | |
Nov 14 2018 | CASI | CASI Pharmaceutica ... | SPARKLE BYTE LTD | 10% Owner | Option Exercise | X | 1.69 | 750,771 | 1,268,803 | 0 | |
Nov 14 2018 | CASI | CASI Pharmaceutica ... | SPARKLE BYTE LTD | 10% Owner | Option Exercise | X | 1.69 | 948,982 | 1,603,780 | 0 | |
Nov 14 2018 | CASI | CASI Pharmaceutica ... | SPARKLE BYTE LTD | 10% Owner | Buy | X | 1.69 | 1,699,753 | 2,872,583 | 10,198,518 | 8.5 M to 10.2 M (+20.00 %) |
Oct 02 2018 | CASI | CASI Pharmaceutica ... | Chi George | Chief Financial Off ... | Option Exercise | A | 4.67 | 400,000 | 1,868,000 | 400,000 | |
Jul 13 2018 | CASI | CASI Pharmaceutica ... | CAPITELLI SARA B | VP Fin & Principal ... | Option Exercise | M | 1.99 | 35,000 | 69,475 | 0 | |
Jul 13 2018 | CASI | CASI Pharmaceutica ... | CAPITELLI SARA B | VP Fin & Principal ... | Sell | D | 7.49 | 26,600 | 199,215 | 0 | 26.6 K to 0 (-100.00 %) |
Jul 13 2018 | CASI | CASI Pharmaceutica ... | CAPITELLI SARA B | VP Fin & Principal ... | Payment of Exercise | F | 7.49 | 8,400 | 62,910 | 26,600 | 35 K to 26.6 K (-24.00 %) |
Jul 13 2018 | CASI | CASI Pharmaceutica ... | CAPITELLI SARA B | VP Fin & Principal ... | Buy | M | 1.99 | 35,000 | 69,475 | 35,000 | 0 to 35 K |
Jul 03 2018 | CASI | CASI Pharmaceutica ... | SHROTRIYA RAJESH C MD | Director | Option Exercise | A | 8.23 | 35,000 | 288,050 | 35,000 | |
Jul 03 2018 | CASI | CASI Pharmaceutica ... | SHROTRIYA RAJESH C MD | Director | Option Exercise | A | 8.23 | 35,000 | 288,050 | 35,000 | |
Jul 03 2018 | CASI | CASI Pharmaceutica ... | Huang James | Director | Option Exercise | A | 8.23 | 50,000 | 411,500 | 50,000 | |
Jul 03 2018 | CASI | CASI Pharmaceutica ... | Zhou Quan | Director | Option Exercise | A | 8.23 | 50,000 | 411,500 | 50,000 | |
Jul 03 2018 | CASI | CASI Pharmaceutica ... | Salisbury Franklin Cary jr | Director | Option Exercise | A | 8.23 | 35,000 | 288,050 | 35,000 | |
Jul 03 2018 | CASI | CASI Pharmaceutica ... | Wu Alex | Director | Option Exercise | A | 8.23 | 35,000 | 288,050 | 35,000 | |
Jun 12 2018 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Director | Option Exercise | A | 3.22 | 1,000,000 | 3,220,000 | 1,000,000 | |
Apr 13 2018 | CASI | CASI Pharmaceutica ... | CAPITELLI SARA B | VP Fin & Principal ... | Option Exercise | M | 0.88 | 26,978 | 23,741 | 0 | |
Apr 13 2018 | CASI | CASI Pharmaceutica ... | CAPITELLI SARA B | VP Fin & Principal ... | Sell | D | 6.62 | 18,778 | 124,310 | 0 | 18.8 K to 0 (-100.00 %) |
Apr 13 2018 | CASI | CASI Pharmaceutica ... | CAPITELLI SARA B | VP Fin & Principal ... | Payment of Exercise | F | 6.62 | 8,200 | 54,284 | 18,778 | 27 K to 18.8 K (-30.40 %) |
Apr 13 2018 | CASI | CASI Pharmaceutica ... | CAPITELLI SARA B | VP Fin & Principal ... | Buy | M | 0.88 | 26,978 | 23,741 | 26,978 | 0 to 27 K |
Apr 06 2018 | CASI | CASI Pharmaceutica ... | Huang James | Director | Buy | J | 0.00 | 191 | 0 | 191 | 0 to 191 |
Apr 06 2018 | CASI | CASI Pharmaceutica ... | Huang James | Director | Sell | J | 0.00 | 416,666 | 0 | 0 | 416.7 K to 0 (-100.00 %) |
Mar 23 2018 | CASI | CASI Pharmaceutica ... | IDG-Accel China Growth Fund II ... | 10% Owner | Option Exercise | P | 3.69 | 1,152,839 | 4,253,976 | 81,728 | |
Mar 23 2018 | CASI | CASI Pharmaceutica ... | IDG-Accel China Growth Fund II ... | 10% Owner | Option Exercise | P | 3.69 | 1,152,839 | 4,253,976 | 1,152,839 | |
Mar 23 2018 | CASI | CASI Pharmaceutica ... | IDG-Accel China Growth Fund II ... | 10% Owner | Buy | P | 3.19 | 204,320 | 651,781 | 646,995 | 442.7 K to 647 K (+46.16 %) |
Mar 23 2018 | CASI | CASI Pharmaceutica ... | IDG-Accel China Growth Fund II ... | 10% Owner | Buy | P | 3.19 | 2,882,098 | 9,193,893 | 9,126,375 | 6.2 M to 9.1 M (+46.16 %) |
Mar 21 2018 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Director | Option Exercise | A | 3.69 | 1,234,567 | 4,555,552 | 1,234,567 | |
Mar 21 2018 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Director | Buy | P | 3.24 | 3,086,419 | 9,999,998 | 4,958,024 | 1.9 M to 5 M (+164.91 %) |
Dec 22 2017 | CASI | CASI Pharmaceutica ... | SPECTRUM PHARMACEUTICALS INC | 10% Owner | Buy | P | 0.01 | 611,740 | 6,117 | 4,650,262 | 4 M to 4.7 M (+15.15 %) |
Dec 22 2017 | CASI | CASI Pharmaceutica ... | SPECTRUM PHARMACEUTICALS INC | 10% Owner | Buy | P | 0.01 | 907,356 | 9,074 | 6,897,413 | 6 M to 6.9 M (+15.15 %) |
Oct 11 2017 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Director | Buy | P | 1.95 | 100,000 | 195,000 | 847,527 | 747.5 K to 847.5 K (+13.38 %) |
Oct 10 2017 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Director | Buy | P | 1.86 | 100,000 | 186,000 | 747,527 | 647.5 K to 747.5 K (+15.44 %) |
Oct 10 2017 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Director | Buy | P | 1.80 | 100,000 | 180,000 | 647,527 | 547.5 K to 647.5 K (+18.26 %) |
Oct 06 2017 | CASI | CASI Pharmaceutica ... | Hu Cynthia W. | COO, Gen Counsel an ... | Option Exercise | A | 1.01 | 50,000 | 50,320 | 50,000 | |
Oct 03 2017 | CASI | CASI Pharmaceutica ... | CAPITELLI SARA B | VP Fin & Principal ... | Option Exercise | A | 1.99 | 20,000 | 39,700 | 20,000 | |
Oct 03 2017 | CASI | CASI Pharmaceutica ... | Hu Cynthia W. | COO, Gen Counsel an ... | Option Exercise | A | 1.99 | 50,000 | 99,250 | 50,000 | |
Sep 20 2017 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Director | Buy | P | 1.78 | 34,002 | 60,524 | 547,527 | 513.5 K to 547.5 K (+6.62 %) |
Sep 20 2017 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Director | Buy | P | 1.75 | 173,500 | 303,625 | 513,525 | 340 K to 513.5 K (+51.03 %) |
Sep 18 2017 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Director | Buy | P | 1.49 | 127,702 | 190,276 | 340,025 | 212.3 K to 340 K (+60.15 %) |
Sep 18 2017 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Director | Buy | P | 1.22 | 187,625 | 228,903 | 212,323 | 24.7 K to 212.3 K (+759.68 %) |
Jun 09 2017 | CASI | CASI Pharmaceutica ... | Wu Alex | Director | Option Exercise | A | 1.01 | 35,000 | 35,224 | 35,000 | |
Jun 09 2017 | CASI | CASI Pharmaceutica ... | SHROTRIYA RAJESH C MD | Director | Option Exercise | A | 1.01 | 35,000 | 35,224 | 35,000 | |
Jun 09 2017 | CASI | CASI Pharmaceutica ... | Salisbury Franklin Cary jr | Director | Option Exercise | A | 1.01 | 35,000 | 35,224 | 35,000 | |
Jun 09 2017 | CASI | CASI Pharmaceutica ... | Huang James | Director | Option Exercise | A | 1.01 | 50,000 | 50,320 | 50,000 | |
Jun 09 2017 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Director | Option Exercise | A | 1.01 | 100,000 | 100,640 | 100,000 | |
Jun 09 2017 | CASI | CASI Pharmaceutica ... | Zhou Quan | Director | Option Exercise | A | 1.01 | 50,000 | 50,320 | 50,000 | |
Jun 09 2017 | CASI | CASI Pharmaceutica ... | Hu Cynthia W. | COO, Gen Counsel an ... | Option Exercise | A | 1.01 | 100,000 | 100,640 | 100,000 | |
Jun 09 2017 | CASI | CASI Pharmaceutica ... | CAPITELLI SARA B | VP Fin & Principal ... | Option Exercise | A | 1.01 | 50,000 | 50,320 | 50,000 | |
Apr 05 2017 | CASI | CASI Pharmaceutica ... | Zukiwski Alexander A | Chief Medical Offic ... | Option Exercise | A | 1.34 | 300,000 | 402,000 | 300,000 | |
Apr 05 2017 | CASI | CASI Pharmaceutica ... | Zukiwski Alexander A | Chief Medical Offic ... | Option Exercise | A | 1.34 | 300,000 | 402,000 | 300,000 | |
Nov 01 2016 | CASI | CASI Pharmaceutica ... | SPECTRUM PHARMACEUTICALS INC | 10% Owner | Buy | P | 0.01 | 198,765 | 1,988 | 4,038,522 | 3.8 M to 4 M (+5.18 %) |
Nov 01 2016 | CASI | CASI Pharmaceutica ... | SPECTRUM PHARMACEUTICALS INC | 10% Owner | Buy | P | 0.01 | 521,692 | 5,217 | 3,839,757 | 3.3 M to 3.8 M (+15.72 %) |
Nov 01 2016 | CASI | CASI Pharmaceutica ... | SPECTRUM PHARMACEUTICALS INC | 10% Owner | Buy | P | 0.01 | 294,815 | 2,948 | 5,990,057 | 5.7 M to 6 M (+5.18 %) |
Nov 01 2016 | CASI | CASI Pharmaceutica ... | SPECTRUM PHARMACEUTICALS INC | 10% Owner | Buy | P | 0.01 | 773,790 | 7,738 | 5,695,242 | 4.9 M to 5.7 M (+15.72 %) |
Oct 25 2016 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Director | Option Exercise | A | 1.40 | 202,247 | 283,146 | 202,247 | |
Oct 05 2016 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Director | Option Exercise | A | 1.69 | 374,321 | 632,602 | 374,321 | |
Oct 05 2016 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Director | Option Exercise | A | 1.11 | 366,343 | 406,641 | 366,343 | |
Oct 05 2016 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Director | Buy | P | 1.19 | 1,871,605 | 2,227,210 | 1,871,605 | 0 to 1.9 M |
Oct 05 2016 | CASI | CASI Pharmaceutica ... | Ren Ken Keyong | Chief Executive Off ... | Option Exercise | A | 1.11 | 308,571 | 342,514 | 308,571 | |
Aug 16 2016 | CASI | CASI Pharmaceutica ... | SPECTRUM PHARMACEUTICALS INC | 10% Owner | Buy | P | 0.01 | 66,255 | 663 | 3,318,065 | 3.3 M to 3.3 M (+2.04 %) |
Aug 16 2016 | CASI | CASI Pharmaceutica ... | SPECTRUM PHARMACEUTICALS INC | 10% Owner | Buy | P | 0.01 | 394,942 | 3,949 | 3,251,810 | 2.9 M to 3.3 M (+13.82 %) |
Aug 16 2016 | CASI | CASI Pharmaceutica ... | SPECTRUM PHARMACEUTICALS INC | 10% Owner | Buy | P | 0.01 | 98,271 | 983 | 4,921,452 | 4.8 M to 4.9 M (+2.04 %) |
Aug 16 2016 | CASI | CASI Pharmaceutica ... | SPECTRUM PHARMACEUTICALS INC | 10% Owner | Buy | P | 0.01 | 585,790 | 5,858 | 4,823,181 | 4.2 M to 4.8 M (+13.82 %) |
Jul 06 2016 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Director | Option Exercise | A | 1.10 | 84,507 | 92,958 | 84,507 | |
Jun 29 2016 | CASI | CASI Pharmaceutica ... | SPARKLE BYTE LTD | 10% Owner | Option Exercise | P | 1.69 | 750,771 | 1,268,803 | 1,699,753 | |
Jun 29 2016 | CASI | CASI Pharmaceutica ... | SPARKLE BYTE LTD | 10% Owner | Buy | P | 1.19 | 3,753,855 | 4,467,087 | 8,498,765 | 4.7 M to 8.5 M (+79.11 %) |
Jun 27 2016 | CASI | CASI Pharmaceutica ... | Ren Ken Keyong | Chief Executive Off ... | Option Exercise | A | 1.15 | 86,486 | 99,459 | 86,486 | |
Jun 27 2016 | CASI | CASI Pharmaceutica ... | Hu Cynthia W. | COO, Gen Counsel & ... | Option Exercise | A | 1.15 | 27,027 | 31,081 | 27,027 | |
Jun 27 2016 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Director | Option Exercise | A | 1.15 | 369,805 | 425,276 | 369,805 | |
Jun 03 2016 | CASI | CASI Pharmaceutica ... | Zhou Quan | Director | Option Exercise | A | 1.26 | 50,000 | 63,000 | 50,000 | |
Jun 03 2016 | CASI | CASI Pharmaceutica ... | Ren Ken Keyong | Chief Executive Off ... | Option Exercise | A | 0.86 | 280,701 | 241,431 | 280,701 | |
Jun 03 2016 | CASI | CASI Pharmaceutica ... | Hu Cynthia W. | COO, Gen Counsel & ... | Option Exercise | A | 0.86 | 87,719 | 75,447 | 87,719 | |
Jun 03 2016 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Director | Option Exercise | A | 0.86 | 712,112 | 612,488 | 712,112 | |
Mar 11 2016 | CASI | CASI Pharmaceutica ... | SPECTRUM PHARMACEUTICALS INC | 10% Owner | Buy | P | 0.01 | 680,113 | 6,801 | 2,856,868 | 2.2 M to 2.9 M (+31.24 %) |
Mar 11 2016 | CASI | CASI Pharmaceutica ... | SPECTRUM PHARMACEUTICALS INC | 10% Owner | Buy | P | 0.01 | 1,008,764 | 10,088 | 4,237,391 | 3.2 M to 4.2 M (+31.24 %) |
Mar 04 2016 | CASI | CASI Pharmaceutica ... | Wu Alex | Director | Option Exercise | A | 0.88 | 35,000 | 30,800 | 35,000 | |
Mar 04 2016 | CASI | CASI Pharmaceutica ... | He Wei-Wu | Director | Option Exercise | A | 0.88 | 100,000 | 88,000 | 100,000 | |
Mar 04 2016 | CASI | CASI Pharmaceutica ... | SHROTRIYA RAJESH C MD | Director | Option Exercise | A | 0.88 | 35,000 | 30,800 | 35,000 | |
Mar 04 2016 | CASI | CASI Pharmaceutica ... | Salisbury Franklin Cary jr | Director | Option Exercise | A | 0.88 | 35,000 | 30,800 | 35,000 | |
Mar 04 2016 | CASI | CASI Pharmaceutica ... | Ren Ken Keyong | Chief Executive Off ... | Option Exercise | A | 0.88 | 125,000 | 110,000 | 125,000 | |
Mar 04 2016 | CASI | CASI Pharmaceutica ... | CAPITELLI SARA B | VP Fin & Principal ... | Option Exercise | A | 0.88 | 35,000 | 30,800 | 35,000 | |
Mar 04 2016 | CASI | CASI Pharmaceutica ... | Huang James | Director | Option Exercise | A | 0.88 | 75,000 | 66,000 | 75,000 | |
Mar 04 2016 | CASI | CASI Pharmaceutica ... | Mak Tak W. | Director | Option Exercise | A | 0.88 | 35,000 | 30,800 | 35,000 | |
Mar 04 2016 | CASI | CASI Pharmaceutica ... | Hu Cynthia W. | COO, Gen Counsel an ... | Option Exercise | A | 0.88 | 95,000 | 83,600 | 95,000 | |
Jan 27 2016 | CASI | CASI Pharmaceutica ... | IDG-Accel China Growth Fund II ... | 10% Owner | Option Exercise | P | 2.91 | 34,479 | 100,334 | 92,044 | |
Jan 27 2016 | CASI | CASI Pharmaceutica ... | IDG-Accel China Growth Fund II ... | 10% Owner | Option Exercise | P | 2.91 | 486,354 | 1,415,290 | 1,298,354 | |
Jan 27 2016 | CASI | CASI Pharmaceutica ... | IDG-Accel China Growth Fund II ... | 10% Owner | Buy | P | 2.40 | 68,958 | 165,499 | 360,947 | 292 K to 360.9 K (+23.62 %) |
Jan 27 2016 | CASI | CASI Pharmaceutica ... | IDG-Accel China Growth Fund II ... | 10% Owner | Buy | P | 2.40 | 972,708 | 2,334,499 | 5,091,438 | 4.1 M to 5.1 M (+23.62 %) |
Jan 21 2016 | CASI | CASI Pharmaceutica ... | Ren Ken Keyong | CEO and Director | Buy | P | 0.71 | 300 | 213 | 15,000 | 14.7 K to 15 K (+2.04 %) |
Jan 21 2016 | CASI | CASI Pharmaceutica ... | Ren Ken Keyong | CEO and Director | Buy | P | 0.72 | 6,063 | 4,365 | 14,700 | 8.6 K to 14.7 K (+70.20 %) |
Jan 21 2016 | CASI | CASI Pharmaceutica ... | Ren Ken Keyong | CEO and Director | Buy | P | 0.74 | 1,100 | 814 | 8,637 | 7.5 K to 8.6 K (+14.59 %) |
Jan 21 2016 | CASI | CASI Pharmaceutica ... | Ren Ken Keyong | CEO and Director | Buy | P | 0.73 | 7,537 | 5,502 | 7,537 | 0 to 7.5 K |
Jan 21 2016 | CASI | CASI Pharmaceutica ... | Ren Ken | CEO and Director | Buy | P | 0.71 | 300 | 213 | 15,000 | 14.7 K to 15 K (+2.04 %) |
Jan 21 2016 | CASI | CASI Pharmaceutica ... | Ren Ken | CEO and Director | Buy | P | 0.72 | 6,063 | 4,365 | 14,700 | 8.6 K to 14.7 K (+70.20 %) |
Jan 21 2016 | CASI | CASI Pharmaceutica ... | Ren Ken | CEO and Director | Buy | P | 0.74 | 1,100 | 814 | 8,637 | 7.5 K to 8.6 K (+14.59 %) |
Jan 21 2016 | CASI | CASI Pharmaceutica ... | Ren Ken | CEO and Director | Buy | P | 0.73 | 7,537 | 5,502 | 7,537 | 0 to 7.5 K |
Jan 21 2016 | CASI | CASI Pharmaceutica ... | Hu Cynthia W. | COO | Buy | P | 0.72 | 11,837 | 8,519 | 17,785 | 5.9 K to 17.8 K (+199.01 %) |
Jan 21 2016 | CASI | CASI Pharmaceutica ... | Hu Cynthia W. | COO | Buy | P | 0.72 | 4,163 | 2,993 | 5,948 | 1.8 K to 5.9 K (+233.22 %) |
Jan 21 2016 | CASI | CASI Pharmaceutica ... | Hu Cynthia W. | COO | Buy | P | 0.75 | 400 | 300 | 1,785 | 1.4 K to 1.8 K (+28.88 %) |
Jan 21 2016 | CASI | CASI Pharmaceutica ... | Hu Cynthia W. | COO | Buy | P | 0.75 | 400 | 299 | 1,385 | 985 to 1.4 K (+40.61 %) |
Apr 08 2015 | CASI | CASI Pharmaceutica ... | SHROTRIYA RAJESH C MD | Director | Option Exercise | A | 1.41 | 35,000 | 49,350 | 35,000 | |
Apr 08 2015 | CASI | CASI Pharmaceutica ... | Salisbury Franklin Cary jr | Director | Option Exercise | A | 1.41 | 35,000 | 49,350 | 35,000 |